Wearable Devices (WLDS) EVP Remez Offir discloses share and option holdings

Rhea-AI Filing Summary

Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.

Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Remez Offir

Role Executive VP of BD

Type	Security	Shares	Price	Value
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock option (right to buy) — 571 shares (Direct); Ordinary Shares — 25,417 shares (Direct)

Footnotes (1)

1. Includes (i) 2,500 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 417 Ordinary Shares through September 10, 2026; and (ii) 16,528 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 486 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share. The options were granted on November 1, 2021 and vest as follows: 190 options vest on the first year anniversary of the grant date and the remaining 381 options vest in equal monthly installments of 16 Ordinary Shares after the first anniversary. The options were granted on August 23, 2023 and vest as follows: 28 options vest on the first year anniversary of the grant date and the remaining 55 options vest in equal monthly installments of 2 Ordinary Shares after the first anniversary.

Key Figures

Direct Ordinary Shares held: 25,417 shares Stock options at $0.72: 571 underlying shares, $0.72 exercise price Stock options at $316.80: 83 underlying shares, $316.80 exercise price +2 more

5 metrics

Direct Ordinary Shares held 25,417 shares Total Ordinary Shares directly owned as of Form 3

Stock options at $0.72 571 underlying shares, $0.72 exercise price Options expiring November 1, 2031

Stock options at $316.80 83 underlying shares, $316.80 exercise price Options expiring November 30, 2033

RSUs vesting through 2026 2,500 shares via RSUs Vest in 417-share monthly installments through September 10, 2026

RSUs vesting through 2029 16,528 shares via RSUs Vest in 486-share monthly installments through January 1, 2029

Key Terms

restricted share units ("RSUs"), Stock option (right to buy), Ordinary Shares

3 terms

restricted share units ("RSUs") financial

"Includes (i) 2,500 ordinary shares... issuable upon the vesting of restricted share units ("RSUs")..."

Stock option (right to buy) financial

"security_title": "Stock option (right to buy)""

Ordinary Shares financial

"Each RSU represents the right to receive one Ordinary Share."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Remez Offir

(Last) (First) (Middle)

5 HA-TNUFA STREET

(Street)

YOKNE'AM ILLIT 2066736

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Wearable Devices Ltd. [ WLDS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP of BD

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	25,417(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	11/01/2022	11/01/2031	Ordinary Shares	571(2)	$0.72	D
Stock option (right to buy)	08/23/2024	11/30/2033	Ordinary Shares	83(3)	$316.8	D

Explanation of Responses:

1. Includes (i) 2,500 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 417 Ordinary Shares through September 10, 2026; and (ii) 16,528 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 486 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

2. The options were granted on November 1, 2021 and vest as follows: 190 options vest on the first year anniversary of the grant date and the remaining 381 options vest in equal monthly installments of 16 Ordinary Shares after the first anniversary.

3. The options were granted on August 23, 2023 and vest as follows: 28 options vest on the first year anniversary of the grant date and the remaining 55 options vest in equal monthly installments of 2 Ordinary Shares after the first anniversary.

	/s/ Offir Remez	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing by Remez Offir at WLDS show?

The Form 3 shows Executive VP of BD Remez Offir’s initial ownership in Wearable Devices Ltd., including 25,417 Ordinary Shares, stock options, and restricted share units that vest over several years as part of his equity compensation.

How many Wearable Devices (WLDS) shares does Remez Offir directly own?

Remez Offir directly owns 25,417 Ordinary Shares of Wearable Devices Ltd. This figure reflects his reported beneficial ownership as of the Form 3 filing date and forms the baseline for any future insider trading disclosures.

What stock options does Remez Offir hold in Wearable Devices Ltd.?

He holds options over 571 Ordinary Shares at a $0.72 exercise price expiring November 1, 2031, and options over 83 Ordinary Shares at a $316.80 exercise price expiring November 30, 2033, all reported as directly owned derivative securities.

What restricted share units (RSUs) are reported for Remez Offir at WLDS?

Footnotes state he has 2,500 Ordinary Shares issuable from RSUs vesting in 417-share monthly installments through September 10, 2026, and 16,528 Ordinary Shares from RSUs vesting in 486-share monthly installments through January 1, 2029, each RSU representing one Ordinary Share.

Does the Remez Offir Form 3 show any recent buy or sell transactions in WLDS stock?

No buy or sell transactions are reported. The Form 3 lists holdings in Ordinary Shares, stock options, and RSUs as of the reporting date, serving as an initial ownership statement rather than documenting new market trades.

What is the significance of the exercise and expiration dates on Offir’s WLDS options?

The options with $0.72 and $316.80 exercise prices expire on November 1, 2031, and November 30, 2033. These dates define how long Offir can choose to exercise his rights to buy Ordinary Shares under each stock option grant.